Treatment-resistant depression is a condition that affects individuals
with Major Depressive Disorder (MDD) who have tried more than two antidepressant
medications and who have not responded to other types of therapies, like
talk-therapy. More than 40% of patients with MDD are considered treatment-resistant.
If you feel you may be experiencing treatment-resistant depression, there is hope.
What is Deep Transcranial Magnetic Stimulations (dTMS)?
We have a treatment that is FDA cleared, known as Deep TMS or Transcranial
Magnetic Stimulation. It is a treatment for people with treatment-resistant
depression. Deep TMS (dTMS) is a noninvasive, outpatient procedure with
no systemic side effects and fits into peoples’ daily routines.
BrainsWay’s patented breakthrough treatment based on Deep TMS™
begins a new era in brain stimulation and research. This non-invasive
and effective treatment activates deep brain structures by using directed
electromagnetic fields that generate excitation or inhibition of neurons
deep inside the brain.
BrainsWay’s Deep TMS flagship technology is based on the H-Coil,
which features a novel patented structure designed to maximize electrical
stimulation of deep brain regions and includes the following unique features:
Coil elements tangential to the head and close to target brain regions
Flexible base suited to head shape
Convergence of numerous electric pulses from various directions
Coil elements parallel to target bundles
Location of return paths of electrical impulses remote from target area
H1 Coil for Major Depression BrainsWay’s treatment was cleared by
the FDA in 2013 for patients who tried any number of antidepressants with
no improvement in the current depressive episode. The FDA indication is
based on a unique 16-week double-blind, placebo-controlled, multi-center
study which enrolled over 200 subjects, and reported a marked decline
in HDRS-21 scores, as well as significant remission (32.6%) and response
(38.4%) rates at the primary endpoint of the study after four weeks of
acute treatment. In the study, treatment with BrainsWay’s H-1 coil
helmet was proven to be safe, and the treatment was well tolerated by
the majority of the study subjects. The H1 Coil is also in clinical trials
at various stages for the treatment of Bipolar Disorder, Post-Traumatic
Stress Disorder and Schizophrenia.
PsychiatryView Profile
